Theranos founder convicted of fraud for claiming to revolutionise healthcare

Theranos, at one point valued at $9bn (£6.5bn), was once the darling of biotech and Silicon Valley. Founder Eizabeth Holmes was able to raise more than $900m from billionaires such as media magnate Rupert Murdoch and tech mogul Larry Ellison.
The firm promised it would revolutionise the healthcare industry with a test that could detect conditions such as cancer and diabetes with only a few drops of blood. However, these claims began to unravel in 2015 after a Wall Street Journal investigation reported that its core blood-testing technology did not work.
 At trial, multiple lab directors testified to telling Holmes about the flaws in Theranos' technology but being instructed to downplay their concerns. At the same time, Holmes told investors the technology was operating as planned while her company secretly relied on commercially available machines to run the tests.
 While jurors found Holmes guilty of conspiracy to commit fraud against investors and three charges of wire fraud, she has denied the charges, which carry a maximum prison term of 20 years each.